FrancophonIA/ELRC3.0 huggingface dataset:
English: Azomyr is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Croatian: Azomyr je indiciran u odraslih i adolescenata u dobi od 12 ili više godina, te u djece u dobi od 6 do 11 godina za ublažavanje simptoma povezanih s: - alergijskim rinitisom (vidjeti dio 5.1) - urtikarijom (vidjeti dio 5.1)
English: What Azomyr oral solution is and what it is used for What you need to know before you take Azomyr oral solution How to take Azomyr oral solution Possible side effects
Croatian: Što je Azomyr oralna otopina i za što se koristi Što morate znati prije nego počnete uzimati Azomyr oralnu otopinu Kako uzimati Azomyr oralnu otopinu Moguće nuspojave
English: Azomyr is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Croatian: Azomyr je indiciran u odraslih i adolescenata u dobi od 12 ili više godina za ublažavanje simptoma povezanih s: - alergijskim rinitisom (vidjeti dio 5.1) - urtikarijom (vidjeti dio 5.1)
English: The safety and efficacy of Azomyr 0.5 mg/ml oral solution in children below the age of 1 year have not been established.
Croatian: Sigurnost i djelotvornost lijeka Azomyr 0,5 mg/ml oralna otopina u djece mlađe od 1 godine nisu ustanovljene.
English: Azomyr has no or negligible influence on the ability to drive and use machines based on clinical trials.
Croatian: Temeljem rezultata kliničkih ispitivanja Azomyr ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: Azomyr is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Croatian: Azomyr se također koristi za ublažavanje simptoma povezanih s urtikarijom (promjene na koži uslijed alergije).
English: If you forget to take Azomyr oral solution
Croatian: Ako ste zaboravili uzeti Azomyr oralnu otopinu
English: EU/1/00/157/001 1 tablet EU/1/00/157/002 2 tablets EU/1/00/157/003 3 tablets EU/1/00/157/004 5 tablets EU/1/00/157/005 7 tablets EU/1/00/157/006 10 tablets EU/1/00/157/007 14 tablets EU/1/00/157/008 15 tablets EU/1/00/157/009 20 tablets EU/1/00/157/010 21 tablets EU/1/00/157/011 30 tablets EU/1/00/157/012 50 tablets EU/1/00/157/013 100 tablets
Croatian: EU/1/00/157/001 1 tableta EU/1/00/157/002 2 tablete EU/1/00/157/003 3 tablete EU/1/00/157/004 5 tableta EU/1/00/157/005 7 tableta EU/1/00/157/006 10 tableta EU/1/00/157/007 14 tableta EU/1/00/157/008 15 tableta EU/1/00/157/009 20 tableta EU/1/00/157/010 21 tableta EU/1/00/157/011 30 tableta EU/1/00/157/012 50 tableta EU/1/00/157/013 100 tableta
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr oral solution.
Croatian: Vezano za trajanje liječenja, Vaš će liječnik odrediti od kojeg tipa alergijskog rinitisa bolujete te koliko dugo trebate uzimati Azomyr oralnu otopinu.
English: Azomyr oral solution is an antiallergy medicine that does not make you drowsy.
Croatian: Azomyr oralna otopina je lijek protiv alergije koji ne izaziva pospanost.
English: In adult and adolescent patients with allergic rhinitis, Azomyr tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Croatian: U odraslih i adolescentskih bolesnika s alergijskim rinitisom, Azomyr tablete su bile učinkovite u ublažavanju simptoma kao što su kihanje, curenje i svrbež nosa, kao i svrbež, suzenje i crvenilo očiju te svrbež nepca.
English: Additionally, Azomyr orodispersible tablet may be taken with or without a meal.
Croatian: Nadalje, Azomyr raspadljive tablete za usta se mogu uzimati neovisno o obroku.
English: If you take more Azomyr orodispersible tablet than you should Take Azomyr orodispersible tablet only as prescribed for you.
Croatian: Ako uzmete više Azomyr raspadljivih tableta za usta nego što ste trebali Uzimajte Azomyr raspadljive tablete za usta samo na način kako Vam je propisano.
English: Azomyr tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Croatian: Azomyr tablete primijenjene u jednokratnoj dnevnoj dozi od 7,5 mg nisu imale učinak na psihomotorne sposobnosti u kliničkim ispitivanjima.
English: What you need to know before you take Azomyr oral solution
Croatian: Što morate znati prije nego počnete uzimati Azomyr oralnu otopinu
English: Adults and adolescents (12 years of age and over) The recommended dose of Azomyr is two 2.5 mg orodispersible tablets placed in the mouth once a day.
Croatian: Odrasli i adolescenti (u dobi od 12 godina i stariji) Preporučena doza lijeka Azomyr su dvije raspadljive tablete za usta od 2,5 mg koje se stavljaju u usta jedanput na dan.
English: Adults and adolescents (12 years of age and over) The recommended dose of Azomyr is 10 ml (5 mg) oral solution once a day.
Croatian: Odrasli i adolescenti (u dobi od 12 ili više godina) Preporučena doza lijeka Azomyr je 10 ml (5 mg) oralne otopine jedanput na dan.
English: What Azomyr oral solution looks like and contents of the pack
Croatian: Kako Azomyr oralna otopina izgleda i sadržaj pakiranja
English: Azomyr orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Croatian: Azomyr raspadljiva tableta za usta se također koristi za ublažavanje simptoma povezanih s urtikarijom (promjene na koži uslijed alergije).
English: At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Azomyr were reported in 3 % of patients in excess of those treated with placebo.
Croatian: U kliničkim ispitivanjima u odraslih i adolescenata kod različitih indikacija, uključujući alergijski rinitis i kroničnu idiopatsku urtikariju kod primjene lijeka Azomyr prijavljene su nuspojave u 3% više bolesnika nego u onih koji su primali placebo.
English: The safety and efficacy of Azomyr 5 mg film-coated tablets in children below the age of 12 years have not been established.
Croatian: Sigurnost i djelotvornost lijeka Azomyr 5 mg filmom obložene tablete u djece mlađe od 12 godina nisu ustanovljene.
English: In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Azomyr tablets were reported in 3 % of patients in excess of those treated with placebo.
Croatian: U kliničkim ispitivanjima kod različitih indikacija, uključujući alergijski rinitis i kroničnu idiopatsku urtikariju, pri preporučenoj dozi od 5 mg na dan, kod primjene lijeka Azomyr prijavljene su nuspojave u 3% više bolesnika nego u onih koji su primali placebo.
English: Azomyr orodispersible tablet contains aspartame This product contains aspartame.
Croatian: Azomyr raspadljive tablete za usta sadrže aspartam
English: What Azomyr orodispersible tablet looks like and contents of the pack
Croatian: Kako Azomyr raspadljiva tableta za usta izgleda i sadržaj pakiranja
English: What Azomyr orodispersible tablet contains
Croatian: Što Azomyr raspadljiva tableta za usta sadrži
English: Do not take Azomyr - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Croatian: Nemojte uzimati Azomyr - ako ste alergični na desloratadin, neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ili na loratadin.
English: Azomyr oral solution is available in bottles of 30, 50, 60, 100, 120, 150, 225 and 300 ml, with a childproof cap. For all packages except the 150 ml bottle, a measuring spoon is provided, marked for doses of 2.5 ml and 5 ml.
Croatian: Azomyr oralna otopina dostupna je u bocama od 30, 50, 60, 100, 120, 150, 225 i 300 ml, sa sigurnosnim zatvaračem za djecu.
English: Azomyr oral solution is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Croatian: Azomyr oralna otopina se također koristi za ublažavanje simptoma povezanih s urtikarijom (promjene na koži uslijed alergije).
English: Azomyr 5 mg tablet desloratadine
Croatian: Azomyr 5 mg tablete desloratadin
English: The safety and efficacy of Azomyr 2.5 mg orodispersible tablets in children below the age of 6 years have not been established.
Croatian: Sigurnost i djelotvornost lijeka Azomyr 2,5 mg raspadljive tablete za usta u djece mlađe od 6 godina nisu ustanovljene.
English: EU/1/00/157/035 5 orodispersible tablets EU/1/00/157/036 6 orodispersible tablets EU/1/00/157/037 10 orodispersible tablets EU/1/00/157/038 12 orodispersible tablets EU/1/00/157/039 15 orodispersible tablets EU/1/00/157/040 18 orodispersible tablets EU/1/00/157/041 20 orodispersible tablets EU/1/00/157/042 30 orodispersible tablets EU/1/00/157/043 50 orodispersible tablets EU/1/00/157/044 60 orodispersible tablets EU/1/00/157/045 90 orodispersible tablets EU/1/00/157/046 100 orodispersible tablets
Croatian: EU/1/00/157/035 5 raspadljivih tableta za usta EU/1/00/157/036 6 raspadljivih tableta za usta EU/1/00/157/037 10 raspadljivih tableta za usta EU/1/00/157/038 12 raspadljivih tableta za usta EU/1/00/157/039 15 raspadljivih tableta za usta EU/1/00/157/040 18 raspadljivih tableta za usta EU/1/00/157/041 20 raspadljivih tableta za usta EU/1/00/157/042 30 raspadljivih tableta za usta EU/1/00/157/043 50 raspadljivih tableta za usta EU/1/00/157/044 60 raspadljivih tableta za usta EU/1/00/157/045 90 raspadljivih tableta za usta EU/1/00/157/046 100 raspadljivih tableta za usta
English: In patients with allergic rhinitis, Azomyr was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Croatian: Kod bolesnika s alergijskim rinitisom, Azomyr je bio učinkovit u ublažavanju simptoma kao što su kihanje, curenje i svrbež nosa, kao i svrbež, suzenje i crvenilo očiju te svrbež nepca.
English: In patients with allergic rhinitis, Azomyr tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Croatian: Kod bolesnika s alergijskim rinitisom, Azomyr tablete su bile učinkovite u ublažavanju simptoma kao što su kihanje, curenje i svrbež nosa, kao i svrbež, suzenje i crvenilo očiju te svrbež nepca.
English: How to store Azomyr
Croatian: Kako čuvati Azomyr
English: How to store Azomyr orodispersible tablet
Croatian: Kako čuvati Azomyr raspadljive tablete za usta
English: Clinical efficacy and safety In a multiple dose trial, Azomyr orodispersible tablets were well tolerated.
Croatian: U ispitivanju primjene višestrukih doza ispitanici su dobro podnosili Azomyr raspadljive tablete za usta.
English: Do not take Azomyr orodispersible tablet - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Croatian: Nemojte uzimati Azomyr raspadljive tablete za usta - ako ste alergični na desloratadin, neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ili na loratadin.
English: EU/1/00/157/047 5 orodispersible tablets EU/1/00/157/048 6 orodispersible tablets EU/1/00/157/049 10 orodispersible tablets EU/1/00/157/050 12 orodispersible tablets EU/1/00/157/051 15 orodispersible tablets EU/1/00/157/052 18 orodispersible tablets EU/1/00/157/053 20 orodispersible tablets EU/1/00/157/054 30 orodispersible tablets EU/1/00/157/055 50 orodispersible tablets EU/1/00/157/056 60 orodispersible tablets EU/1/00/157/057 90 orodispersible tablets EU/1/00/157/058 100 orodispersible tablets
Croatian: EU/1/00/157/047 5 raspadljivih tableta za usta EU/1/00/157/048 6 raspadljivih tableta za usta EU/1/00/157/049 10 raspadljivih tableta za usta EU/1/00/157/050 12 raspadljivih tableta za usta EU/1/00/157/051 15 raspadljivih tableta za usta EU/1/00/157/052 18 raspadljivih tableta za usta EU/1/00/157/053 20 raspadljivih tableta za usta EU/1/00/157/054 30 raspadljivih tableta za usta EU/1/00/157/055 50 raspadljivih tableta za usta EU/1/00/157/056 60 raspadljivih tableta za usta EU/1/00/157/057 90 raspadljivih tableta za usta EU/1/00/157/058 100 raspadljivih tableta za usta
English: Do not take Azomyr oral solution - if you are allergic to desloratadine, or to any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Croatian: Nemojte uzimati Azomyr oralnu otopinu - ako ste alergični na desloratadin, neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ili na loratadin.
English: How to take Azomyr orodispersible tablet
Croatian: Kako uzimati Azomyr raspadljive tablete za usta
English: Azomyr 5 mg film-coated tablets
Croatian: Azomyr 5 mg filmom obložene tablete
English: The safety and efficacy of Azomyr 5 mg orodispersible tablets in children below the age of 12 years have not been established.
Croatian: Sigurnost i djelotvornost lijeka Azomyr 5 mg raspadljive tablete za usta u djece mlađe od 12 godina nisu ustanovljene.
English: A. MANUFACTURIERS RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČI ODGOVORNI ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: Azomyr 5 mg film-coated tablets desloratadine
Croatian: Azomyr 5 mg filmom obložene tablete desloratadin
English: Azomyr oral solution relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 1 year of age and older.
Croatian: Azomyr oralna otopina ublažava simptome povezane s alergijskim rinitisom (upala nosnih puteva uzrokovana alergijom, na primjer, kod peludne groznice ili alergije na grinje) u odraslih osoba, adolescenata i djece u dobi od 1 ili više godina.
English: Azomyr 2.5 mg orodispersible tablets desloratadine
Croatian: Azomyr 2,5 mg raspadljive tablete za usta desloratadin
English: Azomyr relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older.
Croatian: Azomyr ublažava simptome povezane s alergijskim rinitisom (upala nosnih puteva uzrokovana alergijom, na primjer, kod peludne groznice ili alergije na grinje) u odraslih osoba i adolescenata u dobi od 12 ili više godina.
English: Taking Azomyr is not recommended if you are pregnant or nursing a baby.
Croatian: Ako ste trudni ili dojite, nije preporučljivo uzimati Azomyr.
English: Azomyr orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 6 years of age and older.
Croatian: Azomyr raspadljiva tableta za usta ublažava simptome povezane s alergijskim rinitisom (upala nosnih putova uzrokovana alergijom, na primjer, kod peludne groznice ili alergije na grinje) u odraslih, adolescenata i djece u dobi od 6 ili više godina.
English: How to take Azomyr oral solution
Croatian: Kako uzimati Azomyr oralnu otopinu
English: Azomyr 2.5 mg orodispersible tablets
Croatian: Azomyr 2,5 mg raspadljive tablete za usta
English: Azomyr orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older.
Croatian: Azomyr raspadljiva tableta za usta ublažava simptome povezane s alergijskim rinitisom (upala nosnih putova uzrokovana alergijom, na primjer, kod peludne groznice ili alergije na grinje) u odraslih osoba i adolescenata u dobi od 12 ili više godina.
English: Azomyr 2.5 mg orodispersible tablet
Croatian: Azomyr 2,5 mg raspadljiva tableta za usta
English: If you stop taking Azomyr If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se svom liječniku, ljekarniku ili medicinskoj sestri.
English: Azomyr 5 mg orodispersible tablets desloratadine
Croatian: Azomyr 5 mg raspadljive tablete za usta desloratadin
English: Azomyr 5 mg orodispersible tablets
Croatian: Azomyr 5 mg raspadljive tablete za usta
English: How to store Azomyr oral solution
Croatian: Kako čuvati Azomyr oralnu otopinu
English: Azomyr 5 mg orodispersible tablet
Croatian: Azomyr 5 mg raspadljiva tableta za usta
English: As a result, cancer cells cannot divide and they eventually die.
Croatian: Kao rezultat toga, stanice raka ne mogu se dijeliti i naposljetku umiru.
English: It has to be applied with care to stop it getting on areas not affected by the disease.
Croatian: Mora se pažljivo nanositi kako ne bi dospio na područja koja nisu zahvaćena bolešću.
English: Ledaga is a ‘hybrid medicine'.
Croatian: Ledaga je „hibridni lijek”.
English: What is Ledaga and what is it used for?
Croatian: Što je Ledaga i za što se koristi?
English: Ledaga chlormethine
Croatian: Ledaga klormetin
English: This means that it is similar to a ‘reference medicine' (in this case Caryolysine) containing the same active substance and used for the same purpose.
Croatian: To znači da je sličan „referentnom lijeku” (u ovom slučaju lijeku Caryolysine) koji sadrži istu djelatnu tvar i primjenjuje se u istu svrhu.
English: Ledaga was effective in 58% of patients (76 patients out of 130) after at least 6 months of treatment compared with 48% of patients (62 out of 130) using the ointment.
Croatian: Nakon najmanje 6 mjeseci liječenja lijek Ledaga bio je djelotvoran u 58 % bolesnika (76 bolesnika od 130) u usporedbi s 48 % bolesnika (62 od 130) koji su primjenjivali mast.
English: Treatment with Ledaga should be started by a doctor with appropriate experience.
Croatian: Terapiju lijekom Ledaga mora započeti liječnik s odgovarajućim iskustvom.
English: What measures are being taken to ensure the safe and effective use of Ledaga?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i djelotvorna primjena lijeka Ledaga?
English: Effectiveness was measured as complete or partial improvement in the ‘CAILS' score, which takes into account different features of the cancer, such as the size and appearance of the skin damage.
Croatian: Djelotvornost se ocjenjivala na temelju potpunog ili djelomičnog poboljšanja prema bodovnom sustavu CAILS, kojim se u obzir uzimaju različita svojstva raka kao što su veličina i izgled oštećenja kože.
English: What are the risks associated with Ledaga?
Croatian: Koji su rizici povezani s lijekom Ledaga?
English: The company that markets Ledaga will supply materials to prevent accidental contact with the medicine, especially in the eye and the inside of the nose and mouth.
Croatian: Kompanija koja lijek Ledaga stavlja u promet osigurat će materijale za sprječavanje slučajnog kontakta s lijekom, osobito na očima te u nosu i ustima.
English: The full EPAR for Ledaga can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Ledaga nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Ledaga.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Ledaga.
English: In addition, a study involving 260 patients found that Ledaga was at least as effective as an ointment containing the same amount of chlormethine.
Croatian: Osim toga, u ispitivanju koje je uključivalo 260 bolesnika utvrđeno je da je lijek Ledaga barem jednako djelotvoran kao i mast koja sadrži jednaku količinu klormetina.
English: The most common side effects with Ledaga (which may affect more than 1 in 10 people) are dermatitis (skin inflammation with reddening, rash, pain and burning sensation), skin infection and itching.
Croatian: Najčešće su nuspojave lijeka Ledaga (koje se mogu javiti u više od 1 na 10 osoba) dermatitis (upala kože kod koje dolazi do crvenila, osipa i peckanja), infekcija kože i svrbež.
English: The summary of the opinion of the Committee for Orphan Medicinal Products for Ledaga can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
Croatian: Sažetak mišljenja Odbora za lijekove za rijetke bolesti za lijek Ledaga dostupan je na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
English: Other information about Ledaga
Croatian: Ostale informacije o lijeku Ledaga
English: Alkylating agents work by attaching to the DNA of cells while the cells are dividing.
Croatian: Alkilirajući agensi djeluju vezivanjem na stanice DNK dok se stanice dijele.
English: The materials will include a sealable, child-resistant plastic bag for safely storing the medicine in a refrigerator, together with a patient alert card with instructions on the correct way to apply the medicine.
Croatian: Materijali će uključivati plastičnu vrećicu sa zatvaračem, sigurnu za djecu, za sigurno čuvanje lijeka u hladnjaku te karticu s upozorenjima za bolesnika koja sadrži upute o ispravnom načinu primjene lijeka.
English: Why is Ledaga approved?
Croatian: Zašto je lijek Ledaga odobren?
English: It is not intended to provide practical advice on how to use Ledaga.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Ledaga.
English: Therefore, the CHMP's view was that, as for Caryolysine, the benefits outweigh the identified risks.
Croatian: Stoga je stav CHMP-a da, kao i u slučaju lijeka Caryolysine, koristi nadmašuju utvrđene rizike.
English: Treatment should be stopped if patients develop blisters or open sores.
Croatian: Liječenje treba prekinuti ako se u bolesnika jave plikovi ili otvorene rane.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ledaga have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i djelotvorne primjene lijeka Ledaga nalaze se također u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: Because the number of patients with this skin cancer is low, the disease is considered ‘rare', and Ledaga was designated an ‘orphan medicine' (a medicine used in rare diseases) on 22 May 2012.
Croatian: Budući da je broj bolesnika s ovom vrstom raka kože nizak, bolest se smatra „rijetkom” te se lijek Ledaga označava kao lijek za rijetku bolest od 9. prosinca 2011.
English: For more information about treatment with Ledaga, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Ledaga pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: Ledaga can only be obtained with a prescription.
Croatian: Ledaga se izdaje samo na recept.
English: How is Ledaga used?
Croatian: Kako se Ledaga koristi?
English: The difference between Ledaga and Caryolysine is that Ledaga is available as a gel and Caryolysine was available as a liquid for diluting before applying to the skin.
Croatian: Razlika između lijekova Ledaga i Caryolysine jest u tome da je lijek Ledaga dostupan u obliku gela, dok je Caryolysine bio dostupan u obliku tekućine koja se razrjeđuje prije nanošenja na kožu.
English: The active substance in Ledaga, chlormethine, belongs to the group of cancer medicines called ‘alkylating agents'.
Croatian: Djelatna tvar u lijeku Ledaga, klormetin, pripada skupini lijekova za liječenje raka zvanih „alkilirajući agensi”.
English: What benefits of Ledaga have been shown in studies?
Croatian: Koje su koristi lijeka Ledaga utvrđene u ispitivanjima?
English: The medicine contains the active substance chlormethine.
Croatian: Lijek sadrži djelatnu tvar klormetin.